| scholarly article | Q13442814 |
| P50 | author | Alessio Tovaglieri | Q86532838 |
| Kevin M Haigis | Q87900780 | ||
| Douglas A. Lauffenburger | Q59755238 | ||
| P2093 | author name string | Katherine R Baldwin | |
| Vijay Yajnik | |||
| Jesse Lyons | |||
| Jessica J Gierut | |||
| David T Breault | |||
| Alina Starchenko | |||
| Emily J Poulin | |||
| Casie Genetti | |||
| Phaedra C Ghazi | |||
| P2860 | cites work | Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR) | Q72034273 |
| Therapeutic effect of a new immunosuppressive agent, everolimus, on interleukin-10 gene-deficient mice with colitis | Q80165547 | ||
| Mouse and human Notch-1 regulate mucosal immune responses. | Q39034381 | ||
| A novel mTOR inhibitor is efficacious in a murine model of colitis | Q39928484 | ||
| Repression of Mammalian Target of Rapamycin Complex 1 Inhibits Intestinal Regeneration in Acute Inflammatory Bowel Disease Models | Q41706706 | ||
| Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling. | Q42722489 | ||
| Early-stage blocking of Notch signaling inhibits the depletion of goblet cells in dextran sodium sulfate-induced colitis in mice | Q43156844 | ||
| Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. | Q45299244 | ||
| Use of sirolimus (rapamycin) to treat refractory Crohn's disease | Q46417377 | ||
| A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease | Q46451550 | ||
| Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis. | Q51771968 | ||
| Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. | Q51803667 | ||
| Sirolimus ameliorates inflammatory responses by switching the regulatory T/T helper type 17 profile in murine colitis. | Q51825944 | ||
| Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium | Q63406947 | ||
| Guidelines for the management of inflammatory bowel disease in adults | Q22242049 | ||
| Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease | Q22251082 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| QIIME allows analysis of high-throughput community sequencing data | Q24616873 | ||
| The mTOR pathway and integrating immune regulation | Q26830354 | ||
| Multi-scale in vivo systems analysis reveals the influence of immune cells on TNF-α-induced apoptosis in the intestinal epithelium | Q27318698 | ||
| Rapalogs and mTOR inhibitors as anti-aging therapeutics | Q28286510 | ||
| Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells | Q29614268 | ||
| Genetics and pathogenesis of inflammatory bowel disease | Q29616350 | ||
| DADA2: High-resolution sample inference from Illumina amplicon data | Q31099919 | ||
| Broadly permissive intestinal chromatin underlies lateral inhibition and cell plasticity. | Q34118027 | ||
| Intestinal epithelial cells in inflammatory bowel diseases | Q34136264 | ||
| The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markers | Q34280882 | ||
| Role of Janus kinase 3 in mucosal differentiation and predisposition to colitis | Q34371948 | ||
| mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile | Q36003240 | ||
| TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium. | Q36347242 | ||
| mTOR disruption causes intestinal epithelial cell defects and intestinal atrophy postinjury in mice | Q36570898 | ||
| T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade | Q37100252 | ||
| Chronic Repression of mTOR Complex 2 Induces Changes in the Gut Microbiota of Diet-induced Obese Mice | Q37137264 | ||
| In vivo systems analysis identifies spatial and temporal aspects of the modulation of TNF-α-induced apoptosis and proliferation by MAPKs | Q37657176 | ||
| Network analysis of differential Ras isoform mutation effects on intestinal epithelial responses to TNF-α. | Q37666240 | ||
| In vitro expansion and genetic modification of gastrointestinal stem cells in spheroid culture. | Q37672580 | ||
| Pharmacological control of autophagy: therapeutic perspectives in inflammatory bowel disease and colorectal cancer. | Q38013293 | ||
| Intestinal epithelial cells: regulators of barrier function and immune homeostasis | Q38190874 | ||
| The use of sirolimus (rapamycin) in the management of refractory inflammatory bowel disease in children. | Q38252815 | ||
| Diverse adult stem cells share specific higher-order patterns of gene expression. | Q38513522 | ||
| Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease | Q38542147 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e2002417 | |
| P577 | publication date | 2018-03-29 | |
| P1433 | published in | PLOS Biology | Q1771695 |
| P1476 | title | The colonic epithelium plays an active role in promoting colitis by shaping the tissue cytokine profile | |
| P478 | volume | 16 |
| Q93219752 | Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD |
| Q90740755 | Substrate-based kinase activity inference identifies MK2 as driver of colitis |
| Q92703579 | mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn's Disease |
Search more.